These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23406679)

  • 1. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
    Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
    J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
    Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
    J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
    Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
    PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of the miR-34a in hematological malignancies.
    Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
    Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of MIR203 in multiple myeloma.
    Wong KY; Liang R; So CC; Jin DY; Costello JF; Chim CS
    Br J Haematol; 2011 Sep; 154(5):569-78. PubMed ID: 21707582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
    Zhang MY; Wang LQ; Chim CS
    Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
    J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
    Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
    Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Silencing of Tumor Suppressor lncRNA
    Zhang MY; Calin G; Deng MD; Au-Yeung RKH; Wang LQ; Chim CS
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Yim RL; Wong KY; Kwong YL; Loong F; Leung CY; Chu R; Lam WW; Hui PK; Lai R; Chim CS
    Oncotarget; 2014 Oct; 5(20):9770-82. PubMed ID: 25211095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
    Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
    Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
    Tao YF; Xu LX; Lu J; Cao L; Li ZH; Hu SY; Wang NN; Du XJ; Sun LC; Zhao WL; Xiao PF; Fang F; Li YH; Li G; Zhao H; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    J Transl Med; 2014 Jun; 12():182. PubMed ID: 24962166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
    Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
    BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.
    Guillaumet-Adkins A; Richter J; Odero MD; Sandoval J; Agirre X; Catala A; Esteller M; Prósper F; Calasanz MJ; Buño I; Kwon M; Court F; Siebert R; Monk D
    J Hematol Oncol; 2014 Jan; 7():4. PubMed ID: 24405639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
    Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.